These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18454774)

  • 21. The cost of providing methadone maintenance treatment in Ontario, Canada.
    Zaric GS; Brennan AW; Varenbut M; Daiter JM
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):559-66. PubMed ID: 22783917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost and cost-effectiveness of standard methadone maintenance treatment compared to enriched 180-day methadone detoxification.
    Masson CL; Barnett PG; Sees KL; Delucchi KL; Rosen A; Wong W; Hall SM
    Addiction; 2004 Jun; 99(6):718-26. PubMed ID: 15139870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-utility analysis of methadone maintenance treatment in Lithuania.
    Vanagas G; Padaiga Z; Bagdonas E
    Medicina (Kaunas); 2010; 46(4):286-92. PubMed ID: 20571298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Program changes and retention on methadone.
    Maddux JF; Vogtsberger KN; Desmond DP; Esquivel M
    J Subst Abuse Treat; 1993; 10(6):585-8. PubMed ID: 8308944
    [No Abstract]   [Full Text] [Related]  

  • 25. Estimate cost of providing methadone maintenance treatment at a methadone clinic in Nairobi Kenya: direct costs.
    Mogaka B; Kiburi SK; Mutinda M; Kendagor M
    Pan Afr Med J; 2021; 38():84. PubMed ID: 33889250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment program operations and costs.
    Broome KM; Knight DK; Joe GW; Flynn PM
    J Subst Abuse Treat; 2012 Mar; 42(2):125-33. PubMed ID: 22154033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment Cost Analysis Tool (TCAT) for estimating costs of outpatient treatment services.
    Flynn PM; Broome KM; Beaston-Blaakman A; Knight DK; Horgan CM; Shepard DS
    Drug Alcohol Depend; 2009 Feb; 100(1-2):47-53. PubMed ID: 19004576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic vulnerability of methadone maintenance patients: Implications for policies on co-payment services.
    Tran BX; Phan HT; Nguyen LH; Nguyen CT; Nguyen AT; Le TN; Latkin CA
    Int J Drug Policy; 2016 May; 31():131-7. PubMed ID: 26922633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicaid Coverage for Methadone Maintenance and Use of Opioid Agonist Therapy in Specialty Addiction Treatment.
    Saloner B; Stoller KB; Barry CL
    Psychiatr Serv; 2016 Jun; 67(6):676-9. PubMed ID: 26927578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness of disulfiram: treating cocaine use in methadone-maintained patients.
    Jofre-Bonet M; Sindelar JL; Petrakis IL; Nich C; Frankforter T; Rounsaville BJ; Carroll KM
    J Subst Abuse Treat; 2004 Apr; 26(3):225-32. PubMed ID: 15063917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
    Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
    J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV transmission and the cost-effectiveness of methadone maintenance.
    Zaric GS; Barnett PG; Brandeau ML
    Am J Public Health; 2000 Jul; 90(7):1100-11. PubMed ID: 10897189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linking opioid-dependent hospital patients to drug treatment: Health care use and costs 6 months after randomization.
    Barnett PG; Masson CL; Sorensen JL; Wong W; Hall S
    Addiction; 2006 Dec; 101(12):1797-804. PubMed ID: 17156179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Access to publicly funded methadone maintenance treatment in two western states.
    Deck D; Carlson MJ
    J Behav Health Serv Res; 2004; 31(2):164-77. PubMed ID: 15255224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction.
    Byford S; Barrett B; Metrebian N; Groshkova T; Cary M; Charles V; Lintzeris N; Strang J
    Br J Psychiatry; 2013 Nov; 203(5):341-9. PubMed ID: 24029536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns in admission delays to outpatient methadone treatment in the United States.
    Gryczynski J; Schwartz RP; Salkever DS; Mitchell SG; Jaffe JH
    J Subst Abuse Treat; 2011 Dec; 41(4):431-9. PubMed ID: 21821378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Costs-analysis of methadone program in the autonomous community La Rioja, Spain].
    Del Pozo Iribarría J; Soldevilla Iñiguez D; Murga García JA; Antoñanzas Villar F
    Rev Esp Salud Publica; 2012 Oct; 86(5):543-9. PubMed ID: 23223766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM; Raskin IE; Blacklow B
    Subst Use Misuse; 2008; 43(5):647-79. PubMed ID: 18393082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.